Growth hormone and the heart
- PMID: 10207260
- DOI: 10.1159/000057420
Growth hormone and the heart
Abstract
Until a few years ago, growth hormone (GH) and insulin-like growth factor-1 (IGF-1) were considered essential only to the control of linear growth, glucose homeostasis, and for the maintenance of skeletal muscle mass. A large body of evidence recently coming from animal and human studies has unequivocally proven that the heart is a target organ for the GH/IGF-1 axis. Specifically GH exerts both direct and indirect cardiovascular actions. Among the direct effects, the ability of GH to trigger cardiac tissue growth plays a pivotal role. Another direct effect is to augment cardiac contractility, independent of myocardial growth. Direct effects of GH also include the improvement of myocardial energetics and mechanical efficiency. Indirect effects of GH on the heart include decreased peripheral vascular resistance (PVR), expansion of blood volume, increased glomerular filtration rate, enhanced respiratory activity, increased skeletal muscle performance, and psychological well-being. Among them, the most consistently found is the decrease of PVR. GH may also raise preload through its sodium-retaining action and its interference with the hormonal system that regulates water and electrolyte metabolism. Particularly important is the effect of GH on skeletal muscle mass and performance. Taking into account that heart failure is characterized by left ventricular dilation, reduced cardiac contractility, and increase of wall stress and peripheral vascular resistance, GH may be beneficial for treatment of heart failure. Animal studies and preliminary human trials have confirmed the validity of the GH approach to the treatment of heart failure. Larger placebo-controlled human studies represent the main focus of future investigations.
Similar articles
-
Growth hormone, acromegaly, and heart failure: an intricate triangulation.Clin Endocrinol (Oxf). 2003 Dec;59(6):660-71. doi: 10.1046/j.1365-2265.2003.01780.x. Clin Endocrinol (Oxf). 2003. PMID: 14974906 Review.
-
[Growth hormone secretion in heart failure].Minerva Endocrinol. 2003 Mar;28(1):1-11. Minerva Endocrinol. 2003. PMID: 12621359 Review. Italian.
-
Role of growth hormone in chronic heart failure: therapeutic implications.Ital Heart J. 2000 Nov;1(11):732-8. Ital Heart J. 2000. PMID: 11110515 Review.
-
Role of growth hormone in chronic heart failure. Therapeutic implications.Drugs. 2000 Oct;60(4):711-9. doi: 10.2165/00003495-200060040-00002. Drugs. 2000. PMID: 11085197 Review.
-
Growth hormone: a new therapy for heart failure?Baillieres Clin Endocrinol Metab. 1998 Jul;12(2):217-31. doi: 10.1016/s0950-351x(98)80019-0. Baillieres Clin Endocrinol Metab. 1998. PMID: 10083893 Review.
Cited by
-
Influence of puberty on relationships between body composition and blood pressure: a cross-sectional study.Pediatr Res. 2023 Aug;94(2):781-788. doi: 10.1038/s41390-023-02503-7. Epub 2023 Feb 7. Pediatr Res. 2023. PMID: 36750741 Free PMC article.
-
Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience.Endocr Connect. 2015 Mar;4(1):65-75. doi: 10.1530/EC-14-0132. Epub 2015 Jan 19. Endocr Connect. 2015. PMID: 25600246 Free PMC article.
-
Growth hormone and insulin-like growth factor-I alter hippocampal excitatory synaptic transmission in young and old rats.Age (Dordr). 2013 Oct;35(5):1575-87. doi: 10.1007/s11357-012-9460-4. Epub 2012 Aug 1. Age (Dordr). 2013. PMID: 22851280 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous